Affiliation:
1. New York University School of Medicine, Department of Psychiatry, and the
Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, USA, citrome@nki.rfmh.org
2. Leeds Mental Health NHS Teaching Trust, and the University of Leeds,
Clarence House, 11 Clarence Road, Leeds LS18 4LB, UK
Abstract
The effective management of individuals with severe mental illnesses (SMIs) requires an holistic approach that offers reliable symptom control, but also addresses other clinical, emotional and social needs. The physical health of individuals with an SMI is often poor, with many being overweight or obese, having hypertension, diabetes or dyslipidaemia, and at significant risk of developing cardiovascular disease or other comorbidities. We have recently reviewed current UK and US guidelines for the management of individuals with schizophrenia and bipolar disorder, and found very different approaches to the holistic care of people with SMIs, especially in relation to the management of physical health and cardiovascular risk. UK guidelines acknowledge the high risk of physical morbidity and mortality in individuals with an SMI, but fail to address in detail the specifics of physical health monitoring and lifestyle management. US guidelines are more descriptive in terms of the type and extent of monitoring recommended, but there are inconsistencies between the guidelines produced by different organizations, and studies in the field suggest that none of them is being adequately implemented. Clear and consistent recommendations on how and when to monitor weight, cardiovascular function, and metabolic parameters and, importantly, what to do with the results, would support clinicians wishing to integrate physical and mental healthcare. Publication of specific recommendations on evidence-based physical health interventions that can work for people with SMIs would also help primary care and mental health services improve general well-being in their patients with severe mental illnesses.
Subject
Pharmacology (medical),Psychiatry and Mental health,Pharmacology
Reference30 articles.
1. Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
2. Buckley P F, Miller D D, Singer B, Arena J, Stirewalt E M (in press) Clinicians’ appreciation of the metabolic adverse effects of antipsychotic medications. Schizophrenia Research
Cited by
82 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献